Naringenin improves ovarian health by reducing the serum androgen and eliminating follicular cysts in letrozole-induced polycystic ovary syndrome in the Sprague Dawley rats.

Rashid R, Tripathi R, Singh A, Sarkar S, Kawale A, Bader GN, Gupta S, Gupta RK, Jha RK. Naringenin improves ovarian health by reducing the serum androgen and eliminating follicular cysts in letrozole-induced polycystic ovary syndrome in the Sprague Dawley rats. Phytother Res. 2023 Sep; 37(9):4018-4041.

View in: PubMed

subject areas

Androgens
Animals
Disease Models, Animal
Female
Follicular Cyst
Humans
Metformin
Polycystic Ovary Syndrome
Proto-Oncogene Proteins c-akt
Rats
Rats, Sprague-Dawley

authors with profiles

Rajesh Jha, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support